Today, #pharma leaders are tasked with making quick, data-driven decisions while also ensuring meaningful customer engagement. For this dependence on #data, Infosys explores a potential solution with open data sources like the UK National Health Service (NHS). Their datasets offer valuable insights into the UK pharmaceutical ecosystem, enabling productivity and competitiveness. How can the NHS open datasets drive data-led decisions for you? Read more: infy.com/3MjQRA2 #InfyLifeSciences #LifeSciences #BreakthroughsForLife
Über uns
Infosys is a global leader in next-generation digital services and consulting. We enable clients in 46 countries to navigate their digital transformation. Technological advancements and focus on patient centric business models is creating tremendous new opportunities for the pharma industry. While shrinking R&D pipeline, regulatory pressures and drug pricing still continue to be the top challenges, pharma companies are leveraging the latest in Automation, Data Science, Digital, AI, AR/VR, IOT and other new technologies to gain momentum across the value chain – accelerate drug discovery, improve clinical trial effectiveness, reduce time to market for new drugs, find novel treatments that work on smaller groups and are more effective. Infosys is helping Lifesciences companies focus on their objectives by leveraging: AI-powered data core to deliver insights; Experience layer at scale; Always-on learning.
- Website
-
http://www.infosys.com/LifeSciences
External link for Infosys Life Sciences
- Industrie
- IT-Dienstleistungen und IT-Beratung
- Größe des Unternehmens
- 10.001+ Mitarbeiter
- Spezialitäten
- IT Solutions and Services, Consulting, Business Process Outsourcing, Products and Platforms, Engineering Services, Cloud Services, Artificial Intelligence, Digital, and Big Data
Aktualisierungen
-
Recharge your digital exposure with Infosys! In the #digital era, connected devices and #data explosion have together opened up a new world of possibilities for enhancing stakeholder reach and improving health outcomes. At Infosys, we help you navigate this digital landscape, enabling you to leverage digital opportunities for greater operational efficiency, marketing effectiveness, and connected devices. Are you eager to transform your digital ecosystem? Click here: infy.com/4fZKkYQ #InfyLifeSciences #LifeSciences #BreakthroughsForLife
-
-
For a pharma brand manager struggling to close, a data analyst shows how one idea changes the game. Read our graphic novel ‘A Brew For Change’ to learn more. infy.com/3XcIXyD #BreakthroughsForLife #InfyLifeSciences
-
-
Approximately 30% of staff time in #lifesciences is dedicated to documentation-related activities, highlighting the crucial need for efficient documentation practices. The blog, "Unlocking the value of your current content management system", by BASE Life Science, an Infosys company, delves into the complexities in the documentation and how leveraging a robust content management system, like #Veeva Vault, can streamline these processes: bit.ly/3WY8Alz #InfyLifeSciences #BreakthroughsForLife
-
-
The #lifesciences industry is witnessing substantial shifts in R&D and regulatory landscapes. As these become more complex, maintaining comprehensive documentation remains a central factor in staying compliant. Dive into the latest blog by BASE life science, an Infosys company, to explore how a robust content management system can simplify these complexities. #InfyLifeSciences #BreakthroughsForLife
Is your documentation keeping pace with industry demands? In our latest blog article, “Unlocking the value of your current content management system”, we dive into the essential role that thorough documentation plays in life sciences - particularly as R&D becomes more complex and regulations continue to tighten. Read the full blog here 🔗 https://lnkd.in/d9Gbahhp Here’s a glimpse of what’s inside: 🧬 Explore how advancements in genomics and molecular biology are extending R&D timelines and why efficient document management is more crucial than ever. 🌍 Understand the complexities of navigating global regulatory landscapes and how maintaining up-to-date documentation is key to staying compliant. 🔐 Learn about the importance of safeguarding sensitive data and the role of robust documentation in ensuring regulatory compliance and data security. ☁️ Discover how cloud-based solutions are transforming the way companies manage their documentation, with AI and automation leading the charge. --- Discover more on our Veeva Amplifier landing page: https://lnkd.in/dUW5Rfu3
-
-
From enhancing product quality to ensuring regulatory compliance, IoT offers a range of benefits for pharma companies, including inventory tracking and equipment performance monitoring. Uncover how capitalizing on these investment priorities could drive success for pharma as we explore this and more trends in our latest journal: infy.com/4ds4s4g #InfyLifeSciences #LifeSciences #BreakthroughsForLife #Pharma
-
In a landscape where R&D investments often represent a significant portion of costs, the rise of virtual trials offers a promising opportunity. How can organizations harness AI's data handling capabilities here, to potentially reduce study costs and build substantial savings? Learn more in our latest journal: infy.com/3WJnkof #InfyLifeSciences #LifeSciences #BreakthroughsForLife #Digital
-
An estimated investment of nearly $1.5 billion into virtual trials in the next two years signals a transformative shift in the industry. This upsurge, primarily driven by the largest revenue companies, presents significant opportunities for those ready to adapt. Learn how virtual trials are shaping the industry in our recently published journal: infy.com/3yFmvon #InfyLifeSciences #LifeSciences #BreakthroughsForLife #Digital
-
Uncovering the dynamic impact of GenAI in #lifesciences, our recent survey highlights its remarkable success in sales and marketing use cases. However, the landscape changes when moving to sectors like supply chain and manufacturing. Are you eager to unravel more about the ROI delivery of #GenAI applications? Check out our recent journal: infy.com/3LU4w0w #InfyLifeSciences #BreakthroughsForLife #AI
-
Digital therapeutics are reshaping how patients manage their treatments, helping them navigate complex dosing requirements and self-administration. Our latest publication breaks down how this could be a game-changer by offering patients personalized educational materials, dosing instructions, and even side effect monitoring tools: infy.com/3YmJvD7 #InfyLifeSciences #LifeSciences #BreakthroughsForLife #Digital